Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-23

FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cilostazol from Teva Pharmaceuticals USA, Inc., updating the labeling for the drug. This constitutes a supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)